October 3rd, 2016

Johnson & Johnson’s Dr. Paul Janssen Award Winner Receives the Nobel Prize in Medicine

By Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson


Dr. Stoffels (left) with Dr. Ohsumi

The long road to scientific discovery starts with a question.

For Dr. Paul Janssen, that question was: “What’s new?” This was the basic inquiry and profound challenge he posed to the scientists who worked in his lab every day—a reminder to always continue researching the innovations that would transform the lives of patients eagerly awaiting new healthcare solutions.

It was a simple question that led to the discovery and development of an astounding 80 new medicines before his death in 2003—medicines that made a difference for millions of patients in the areas of psychiatry, infectious disease, pain management and gastroenterology.

Dr. Paul, as most people called him, was the founder of Janssen Pharmaceutica, which became part of the Johnson & Johnson Family of Companies in 1961. He was one of the most innovative pharmaceutical researchers of our time and a true inspiration.

One of the many ways we keep his spirit alive is by celebrating the outstanding achievements of today’s scientists with the Dr. Paul Janssen Award for Biomedical Research.

Over the past decade, we’ve recognized a remarkable roster of scientists. And while their discoveries are vastly different—ranging from breakthroughs in oncology to pioneering work in viral diseases—they all have one thing in common: They embody the leadership and passion of Dr.

Read More

September 30th, 2016

The Health Warrior: Why Danai Gurira Is Helping Johnson & Johnson Fight HIV/AIDS

If you watched the Global Citizen Festival last weekend, you may have been moved by the powerful call-to-action from award-winning playwright and actress Danai Gurira, who’s partnered with Johnson & Johnson to help fight HIV/AIDS and show how working directly with communities to combat a health crisis has the potential to positively transform generations to come.

Specifically, Gurira’s helping to share the moving story of Nyumbani, a village that became the first sustainable HIV/AIDS community in Africa, allowing nearly half of the children who live there—either because they are HIV-positive or have been orphaned by the disease—to make it to college.

Gurira has actually made it her life’s mission to help bring awareness about communities devastated by the disease. She saw the rise of HIV first-hand growing up in southern Africa, and since then, she’s received critical acclaim for co-writing and acting in “In the Continuum,” a play about two women grappling with their recent HIV diagnoses.

To hear more about why she’s partnering with Johnson & Johnson, check out this inspiring video.

RELATED: Meet 8 Global Leaders of Tomorrow Who Plan to Change the World

Read More

September 28th, 2016

Johnson & Johnson Expands Access to Investigational Medications Through Its CompAC Program

By Joanne Waldstreicher, M.D., Chief Medical Officer, Johnson & Johnson

Doctor-and-PatientAs a physician, mother and daughter, I have a keen understanding of the complexities and importance of fair, objective and timely decision-making when it comes to best serving the health and well-being of not only my patients, but also my parents, my siblings and my children.

My personal experiences shape how I lead our team at Johnson & Johnson in responding to the people we serve.

This is especially evident in the way that we manage access to our experimental treatments, known as compassionate use requests. It is paramount that we, as a company involved in research, respond in a timely and objective manner that balances and supports the needs of individuals in urgent need of new treatments with those of the larger patient community and future patients. Our goal, as developers and researchers of new medicines, is to drive the best possible outcomes for patients and their families today and tomorrow.

As I shared last year, Johnson & Johnson’s recognition of the need to fairly and ethically address compassionate use requests led to our partnership with the New York University (NYU) School of Medicine. Together, we instituted a first-of-its-kind pilot program—the Compassionate Use Advisory Committee (CompAC)—designed to effectively address the complex and emotional challenges associated with the use of investigational medicines.

Read More

September 23rd, 2016

3 Inspiring Stories of What It Means to Participate in the Stephen Siller Tunnel to Towers 5K Run & Walk

By Kera Bolonik


Firefighters at the starting line of last year’s event

On the morning of September 11, 2001, firefighter Stephen Siller had just finished his shift and was on his way to play golf when he got word that a plane had hit the Twin Towers in lower Manhattan. The 34-year-old father of five called his wife to say he was heading back to the firehouse in Brooklyn.

So he grabbed his gear and headed toward the Brooklyn Battery Tunnel—only to find that it had already been closed off. Undeterred, Siller ran through the tunnel, with 60 pounds of gear strapped to his back, to get to the scene of the terrorist attack, where he died saving other people’s lives.

For the past 14 years, the Siller family has paid tribute to his heroic act with the Stephen Siller Tunnel to Towers Foundation 5K Run & Walk, which retraces Stephen’s path that day.

“When we started the foundation, we wanted to honor the sacrifice our little brother made, and what better way to do that than with this big annual event,” says CEO Frank Siller, who created the foundation with his six siblings. “We’re very proud of it because the 5K brings together 9/11 family members with first-responders and military veterans—all the greatness of America.”

In addition to bringing hundreds of people together to commemorate that fateful day, the event also helps raise funds for such programs as the foundation’s Building for America’s Bravest, an initiative to construct custom “smart homes” for severely injured U.S.

Read More

September 21st, 2016

Why Johnson & Johnson Is Proud to Support the United Nations and the Syrian Refugee Crisis

By Alex Gorsky, Chairman & CEO, Johnson & Johnson

United in Global Health

The United Nations General Assembly takes place this week at United Nations Headquarters

This week marks the 71st meeting of the United Nations General Assembly (UNGA), an event that will call together 193 member nations in New York.

The backdrop for this session is pretty bleak. Around the world, we see conflicting political ideologies, ethnic and religious conflict, and economic crises. We’re constantly reminded of the things that divide us. That’s why I believe it’s so important, now more than ever, to consider the things that unite us. Health & wellness is one common issue that unites all people around the world, especially those of us at Johnson & Johnson.

Together, we believe that health is the foundation for all human development, enabling children to thrive, women and men to succeed, communities to prosper, and countries to rise out of poverty.

Health & wellness is a big focus of UNGA. Yesterday I participated in a White House Roundtable with President Obama and other leaders to chart our progress on the Sustainable Development Goals agreed to by the United Nations a year ago. But our attention was heavily focused on one of the greatest challenges: the Syrian refugee crisis.

Read More

September 21st, 2016

Why It Really Does Take a Village to Make the World a Healthier Place

By Michael Sneed, Worldwide Vice President, Global Corporate Affairs, and Chief Communication Officer


Nyumbani Village provides a home for children impacted by HIV/AIDS, like this little boy

At Johnson & Johnson, we believe in the power of society coming together to advance the health and well-being of people around the world. It’s a belief that’s woven into the fabric of what we do as a company, particularly when it comes to partnering with organizations that have the potential to positively impact the lives of people worldwide.

This is why we recently joined forces with Global Citizen, a social action platform aimed at connecting people with events, campaigns and organizations focused on helping combat poverty across the globe.

By combining our expertise in healthcare with Global Citizen’s approach to community engagement, we hope to create large-scale change that can address some of the world’s most pressing health challenges, such as eradicating polio and tuberculosis and helping reduce mother-to-child HIV transmissions.

RELATED: Meet 8 Young Global Leaders of Tomorrow Who Plan to Change the World

It Takes a Village to Drive Change
For the past two weeks, our joint campaign has motivated people to be change agents by taking such simple social media actions as signing online petitions and tweeting socially-minded content that had the potential to go viral.

Read More

September 21st, 2016

Meet 8 Young Global Leaders of Tomorrow Who Plan to Change the World

By Meghan Rabbitt

8 Young LeadersFor the past four years, more than 60,000 people have gathered in New York City’s Central Park for an inspiring event known as the Global Citizen Festival, which takes place on September 24 this year.

It’s one part star-studded concert (this year, Rihanna and Metallica will perform) and one part public forum for activists and thought leaders from across the globe to unite with one common cause in mind: end world poverty.

There’s also a twist: Most of the tickets to the festival can’t be bought—you have to win them by performing socially-conscious acts.

Unless, that is, you’re one of 20 young leaders who have been nominated by Johnson & Johnson and the non-profit organizations they work with—humanitarian-focused organizations like Save the Children—to earn a seat at the festival, thanks to a lifetime of good works.

We caught up with eight of these inspiring global citizens to hear more about how they’re well on their way to becoming global leaders of tomorrow.

RELATED: Why It Really Does Take a Village to Make the World a Healthier Place

The HIV EducatorNontokozo Zamacebisa Zakwe
Who: Nontokozo Zamacebisa Zakwe
Where: Durban, South Africa
Age: 24
Works With: The Valley Trust

After her mother was diagnosed with HIV and soon bedridden, Nontokozo Zamacebisa Zakwe, then 19, was faced with a big realization.

Read More

September 21st, 2016

Welcome to Nyumbani: The Village That Gives a Home—and Hope—to Children With HIV

Nyumbani Village

One of the hundreds of children who live and thrive at Nyumbani Village

They are often referred to as Africa’s “lost generation.” They’re children who’ve lost their parents to HIV/AIDs—and are at risk of losing their lives to the disease, too.

Grace Wairimu was one of them.

Wairimu, who is HIV-positive, was abandoned by her mother on the streets of Nairobi, Kenya, when she was just 11. But today, the 24-year-old is not only surviving, but thriving—thanks to a remarkable place known as Nyumbani Village, which has been helping to rewrite the narrative for Kenya’s most vulnerable citizens since 2006.

In Kenya alone, more than 200,000 kids under the age of 14 have been infected with the virus, and an estimated one million have been orphaned due to the epidemic. Nyumbani, located in the town of Kitui, provides a stable place to live for 1,000 children who’ve been displaced by the crisis.

“Nyumbani is a lifeline for so many people in Kenya,” says Lauren Moore, Vice President of Corporate Citizenship for Johnson & Johnson, which supports the village through educational and other programs. “That’s why we’re so proud to help them continue to move their good work forward.”

RELATED: Why It Really Does Take a Village to Make the World a Healthier Place

Along with access to comprehensive medical care, psychosocial support and on-site schooling, Nyumbani provides something else invaluable to its littlest residents: love and nurturing from a network of elders who’ve embraced the role of surrogate parents within the community.

Read More

September 19th, 2016

5 Ways Johnson & Johnson Is Helping to Build a Healthier Planet by 2020

For more than 100 years, Johnson & Johnson has been committed to improving the health of individuals, families and communities around the world. And for the past few decades, we’ve also been increasingly focused on improving the health of the planet through environmentally-conscious practices and programs.

To keep the momentum going well into the next decade and beyond, we recently announced our latest Citizenship and Sustainability 2020 Goals, as well as our plan to continue to partner with the United Nations to help ensure that their 2030 Sustainable Development Goals become a reality, too.

From helping to combat some of the world’s most pervasive diseases to reducing our carbon footprint, check out this infographic to learn about some of the ways Johnson & Johnson has helped keep—and will continue to keep—the globe going strong for generations to come.

RELATED: Healthier Planet, Healthier Society: 4 Ways Johnson & Johnson Made Sustainability Strides in 2015

JNJ Healthy Planet Infographic

Read More

September 8th, 2016

Global Trial Finder: Why It Just Got Easier to Enroll in a Janssen Clinical Study

By Amy RobertsGlobal Trial Finder

More than 35,000 of the world’s most dedicated scientists and innovators work for the Janssen Pharmaceutical Companies of Johnson & Johnson, helping to research and develop new ways to treat and prevent some of the world’s most complex diseases.

But there’s another key component that’s necessary when it comes to finding new therapies for conditions like Alzheimer’s disease, rheumatoid arthritis and cancer: you.

Janssen Research & Development routinely conducts clinical trials to evaluate investigational medications and treatment regimens, and that requires the participation of hundreds—sometimes even thousands—of volunteers.

But finding enough willing and qualified participants can often be a challenge.

Enter the Janssen Global Trial Finder, an easy-to-use database of clinical trials that are currently accepting new participants for a variety of diseases. People interested in enrolling in a study can search by medical condition and geographic location.

“We understand both the health-related reasons people seek to participate in clinical trials, and the motivation to help others who may face similar experiences in the future,” says Bert Hartog, Ph.D., Director and Clinical Trial Innovation Lead at Janssen. “So we wanted to offer a resource for easily accessing our clinical trials globally—a resource that can enable us to continue to advance innovative medicines to treat, prevent, intercept and cure some of the most complex diseases of our time.”


Read More